A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV

NCT02263040 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluzone High-Dose
BIOLOGICAL: Fluzone (standard dose)

Sponsor

Mount Sinai Hospital, Canada